Shin, S.-B.; Kim, D.-H.; Kim, D.-E.; Aldonza, M.B.D.; Kim, Y.; Yim, H.
Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters. Cancers 2021, 13, 4413.
https://doi.org/10.3390/cancers13174413
AMA Style
Shin S-B, Kim D-H, Kim D-E, Aldonza MBD, Kim Y, Yim H.
Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters. Cancers. 2021; 13(17):4413.
https://doi.org/10.3390/cancers13174413
Chicago/Turabian Style
Shin, Sol-Bi, Dae-Hoon Kim, Da-Eun Kim, Mark Borris D. Aldonza, Yoosik Kim, and Hyungshin Yim.
2021. "Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters" Cancers 13, no. 17: 4413.
https://doi.org/10.3390/cancers13174413
APA Style
Shin, S.-B., Kim, D.-H., Kim, D.-E., Aldonza, M. B. D., Kim, Y., & Yim, H.
(2021). Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters. Cancers, 13(17), 4413.
https://doi.org/10.3390/cancers13174413